Fumiki Yoshihara, Yasushi Matsuzawa, Kiyomasa Nakatsuka, Jin Kirigaya, Ichiro Takeuchi, Kazuo Kimura, Masaaki Konishi, Kouichi Tamura, Kazuki Fukui, Kengo Tsukahara, Hiroyuki Shimizu, Keisuke Iwabuchi, Yu Yamada, Kenichiro Saka, Yukihito Sato, Masahiro Ogawa, Kayoko Hayakawa, Norio Ohmagari, Syuhei Ikeda, Masaharu Akao, Hideki Shimomura, Yasuki Kihara, Akihiro Yoshimoto, Masanori Morita, Norihiko Kumada, Soshiro Ogata, Kunihiro Nishimura, Tetsuya Arisato, Miki Matsuo, Masatsugu Kishida, Satoshi Yasuda, Hisao Ogawa
It has not yet been established whether angiotensin II receptor blockers (ARB), statins, and multiple drugs affect the severity of COVID-19. Therefore, we herein performed an observational study on the effects of 1st- and 2nd-generation ARB, statins, and multiple drugs, on COVID-19 in patients admitted to 15 Japanese medical facilities. The results obtained showed that ARB, statins, and multiple drugs were not associated with the primary outcome (odds ratio: 1.040, 95% confidence interval: 0.688-0.571; 0.696, 0...
April 26, 2024: Hypertension Research: Official Journal of the Japanese Society of Hypertension